Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Secondary malignant neoplasm of lymph node
0.100 Biomarker disease BEFREE The clinicopathological analysis revealed that a decrease of miR-148a was significantly correlated with lymph-node metastasis (P<0.01) and tumor node metastasis (TNM) stage (P<0.05). 29541249 2018
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE The data from the current study indicated that miR-148a was significantly downregulated in lung adenocarcinoma tissues and cell lines, and low miR-148a expression was significantly associated with advanced Tumor, Node, Metastasis stages and lymph node metastasis, as well as the shorter survival time of patients. 30546419 2018
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE Low expression of miR-148a in RCC tissues was associated with large tumor size, advanced TNM stage, and lymph node metastasis. 27878305 2017
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE In this research, we demonstrated that miR-148a expression was significantly down-regulated in gastric cancer tissues in comparison with the matched normal mucosal tissues, and its expression was statistically associated with lymph node metastasis. 27518872 2016
Secondary malignant neoplasm of lymph node
0.100 Biomarker disease BEFREE Decreased miR-148a was significantly associated with tumor node metastasis stage and lymph node metastasis. 26584284 2015
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE RESULTS Methylation-specific PCR demonstrated that DNA methylation rate of miR-148a was higher in tumor tissues than in adjacent tissues and healthy tissues (P<0.05). miR-148a expression was proved to be epigenetically regulated after the demethylation of it by 5-aza-20-deoxycytidine treatment and qRT-PCR analysis. miR-148a methylation was significantly influenced by many clinicopathologic characteristics such as age (P=0.000), pathological differentiation (P=0.000), and lymph node metastasis (P=0.000). 26638007 2015
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE We found that miR-148a is significantly downregulated in non-small cell lung cancer (NSCLC) compared to adjacent non-cancerous lung tissues, and the downregulated miR-148a was significantly associated with lymph-node metastasis. 23670799 2013
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE Low miR-148a levels were associated with lymph node metastasis, N stage, and blood vessel invasion. miR-148a overexpression inhibited metastasis of gastric cancer cells. miR-148a overexpression also downregulated vimentin expression and upregulated E-cadherin expression, suggesting that miR-148a inhibited EMT. 23873106 2013
Secondary malignant neoplasm of lymph node
0.100 Biomarker disease BEFREE We found that miR-148a expression was suppressed by more than 4-fold in gastric cancer compared with their corresponding nontumorous tissues, and the downregulated miR-148a was significantly associated with tumor-node-metastasis (TNM) stage and lymph node-metastasis. 21994419 2011
Secondary malignant neoplasm of lymph node
0.100 AlteredExpression disease BEFREE In EAC, miR-148a expression levels were inversely associated with cancer differentiation. miR-21 expression levels were higher in SCC if distant lymph node metastases were present. miR-148a levels were lower when EAC was more proximally located, and miR-21 levels were lower when SCC was more proximal. miR-106a and miR-148a were lower in patients with SCC who developed recurrent disease or had a tumor-related death. 20628822 2011
Secondary malignant neoplasm of lymph node
0.100 PosttranslationalModification disease BEFREE Most important, the involvement of miR-148a, miR-34b/c, and miR-9 hypermethylation in metastasis formation was also suggested in human primary malignancies (n = 207) because it was significantly associated with the appearance of lymph node metastasis. 18768788 2008